Natera | Transforming Management of Genetic Disease.

OUR STORY

State-of-the-art genetic tests for oncology, organ transplantation, and women's health.

IN THE NEWS

Natera receives final Medicare coverage for Prospera transplant assessment test


 

Cancer
monitoring

Personalized testing for each cancer patient, to detect molecular residual disease (MRD) and help guide treatment decisions.

 

Learn more: Oncology

 

Assessing the health
of transplant patients

The most precise cell-free DNA (cfDNA) testing in organ transplantation—developed from our trusted legacy.

 

Learn more: Organ Transplantation

 

Planning
a family

Solutions for all the steps in your journey to parenthood, from starting to plan a family to checking your baby’s health.

 

Learn more: Women's Health


IN THE NEWS

Panorama NIPT achieves 2 million test milestone.

Learn More


OUR CLINICAL EXPERTS

“What I love most about Natera is their patient-centered approach to products and services.”

Sheetal Parmar, Clinical Support Director

Learn More


OUR STORY

Natera's core technology and finely tuned workflows cut through the noise to deliver superior clinical and analytical performance.

Learn More